We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Large-Scale Genetic Screening Could Identify Populations Vulnerable To COVID-19

By HospiMedica International staff writers
Posted on 19 Aug 2020
French researchers have proposed large-scale genetic screening to identify populations vulnerable to COVID-19, according to a Reuters report.

In their hypothesis, the researchers have described two opposing enzyme processes that take place when the coronavirus enters the human body. One process contributes to the infection by helping the virus break into cells, while the other - an opposite process - protects the body by keeping the virus away from its target cells.

Illustration
Illustration

According to the researchers, genetic differences among individuals affect the severity of the infection and the strength of the protection mechanisms, with some people having genes that predispose them to infection while others have genes that strengthen the body's protective process. If a genetic risk score were developed based on the information in the genetic databases analyzed by the researchers, then the populations at risk for severe COVID-19 "could be characterized by specific genetic profiles," study co-author Gerard Milano of Antoine Lacassagne Cancer Center (Nice, France) told Reuters.

Related Links:

Antoine Lacassagne Cancer Center


Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Video Laryngoscope
SH-VL1

Latest COVID-19 News

Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles

World's First Inhalable COVID-19 Vaccine Approved in China

COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles